Levoprotiline

左丙替林

Report date: 2022/01/14 13:23:58

Base Information

Drug NameLevoprotiline
Drug Alias Name(-)-oxaprotiline(R)-Oxaprotiline hydrochlorideLevoprotiline hydrochlorideR-(-)-oxaprotilineCGP-12103A +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistamine H1 receptor antagonistsSerotonin reuptake inhibitors
TargetsHistamine H1 receptorSerotonin transporter
Therapy Area/IndicationsDepressive Disorder, Major
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (NDA/BLA)
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovartis Pharma Ag
Active IndicationsN/A
Inactive IndicationsDepressive Disorder, Major

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG